Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

United Therapeutics Corporation (UTHR)

  • Business News
  • Dec. 23, 2025, 21:40 UTC
  • 11
  • 1 comments

UTHR: Notification

Market reaction Comment Full text

Citius Pharmaceuticals Inc. (CTXR)

  • Business News
  • Dec. 23, 2025, 21:30 UTC
  • 15
  • 1 comments

Citius Oncology - Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update

Market reaction Comment Full text

Citius Pharmaceuticals Inc. (CTXR)

  • Business News
  • Dec. 23, 2025, 21:30 UTC
  • 14
  • 1 comments

Citius Pharmaceuticals, Inc. - Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update

Market reaction Comment Full text

SeaStar Medical Holding Corp (ICU)

  • Business News
  • Dec. 23, 2025, 21:25 UTC
  • 15
  • 1 comments

SeaStar Medical Announces 1-for-10 Reverse Split

Market reaction Comment Full text

Janux Therapeutics Inc (JANX)

  • Business News
  • Dec. 23, 2025, 21:05 UTC
  • 15
  • 1 comments

Janux - Investor Relations - Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study

Market reaction Comment Full text

Henry Schein Inc (HSIC)

  • Business News
  • Dec. 23, 2025, 21:05 UTC
  • 16
  • 1 comments

Henry Schein Provides Update on CEO Search Process

Market reaction Comment Full text

Organogenesis Holdings Inc. (ORGO)

  • Business News
  • Dec. 23, 2025, 21:05 UTC
  • 21
  • 1 comments

Organogenesis Announces Initiation of Biologics License Application for ReNu®

Market reaction Comment Full text

Janux Therapeutics Inc (JANX)

  • Business News
  • Dec. 23, 2025, 21:05 UTC
  • 18
  • 1 comments

Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study

Market reaction Comment Full text

Perrigo Company plc (PRGO)

  • Business News
  • Dec. 23, 2025, 21:04 UTC
  • 20
  • 1 comments

Perrigo Company plc (PRGO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Market reaction Comment Full text

Vor Biopharma Inc (VOR)

  • Business News
  • Dec. 23, 2025, 21:01 UTC
  • 19
  • 1 comments

Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors

Market reaction Comment Full text
  • Previous
  • 233
  • 234
  • 235
  • 236
  • 237
  • Next

Search

News categories

  • Technical Exchange News(10894)
  • Event(2278)
  • SEC News(189750)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124668)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin